Blinding is a study safeguard that hides treatment assignment from participants, researchers, outcome assessors, or data analysts so expectations are less able to shape behavior, measurement, or interpretation.
What gets hidden
Single-blind studies usually hide assignment from participants. Double-blind studies usually hide assignment from both participants and investigators who interact with them. Some trials also blind outcome adjudicators or statisticians, which matters when the endpoint has room for judgment.
The point is not secrecy for its own sake. It is to keep the active compound, placebo, dose, or sequence from changing how people report symptoms, how staff probe for side effects, or how borderline data are classified.
Why it matters
Blinding is one reason a randomized controlled trial can separate a treatment signal from placebo expectancy. If the active product has a distinctive taste, flush, stimulant feel, or stomach effect, the blind can break even when the trial is labeled double-blind.
That matters for supplement claims because many outcomes are subjective: focus, mood, calm, soreness, sleep quality, and perceived energy. If participants can guess assignment, the apparent effect may partly reflect expectation rather than the compound.
Reading a trial
A useful methods section states who was blinded, how the placebo matched the active product, and whether the trial checked guesses about assignment. A weak report only says blind without explaining the mechanics.
Blinding also shapes recommendation ranking. A well-blinded trial earns more trust than an open-label trial when both report the same apparent improvement.
In personal experiments
Home n-of-1 experiments can use blinding when a third party prepares capsules or randomizes blocks. Perfect blinding is rarely practical at home, so the honest move is to record whether the user could guess the active condition.
Safety note
Blinding improves evidence quality. It does not make a compound safer, and it should never hide safety information from a clinician or trial monitor.